media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Kabra Drugs Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]0.000.000.000.020.00
Total Operating Revenues0.000.000.000.020.00
      
Other Income0.010.000.000.000.01
Total Revenue0.010.000.000.020.01
      
EXPENSES     
Employee Benefit Expenses0.230.090.050.000.03
Finance Costs0.000.000.000.000.01
Depreciation And Amortisation Expenses0.000.010.030.030.03
Other Expenses0.110.090.100.050.10
Total Expenses0.340.190.180.080.17
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-0.34-0.19-0.18-0.06-0.16
      
Profit/Loss Before Tax-0.34-0.19-0.18-0.06-0.16
      
Tax Expenses-Continued Operations     
Profit/Loss After Tax And Before ExtraOrdinary Items-0.34-0.19-0.18-0.06-0.16
      
Profit/Loss From Continuing Operations-0.34-0.19-0.18-0.06-0.16
      
Profit/Loss For The Period-0.34-0.19-0.18-0.06-0.16
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-0.77-0.42-0.41-0.140.00
Diluted EPS (Rs.)-0.77-0.42-0.41-0.140.00
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]0.00
Total Operating Revenues0.00
Other Income0.01
Total Revenue0.01
EXPENSES 
Employee Benefit Expenses0.23
Finance Costs0.00
Depreciation And Amortisation Expenses0.00
Other Expenses0.11
Total Expenses0.34
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-0.34
Profit/Loss Before Tax-0.34
Tax Expenses-Continued Operations 
Profit/Loss After Tax And Before ExtraOrdinary Items-0.34
Profit/Loss From Continuing Operations-0.34
Profit/Loss For The Period-0.34
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-0.77
Diluted EPS (Rs.)-0.77